We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Microfluidic System Enables Early Cancer Diagnosis Using Simple Blood Tests

By LabMedica International staff writers
Posted on 31 Jul 2025

Circulating tumor cells (CTCs), which break off from primary tumors and travel through the bloodstream, pose a significant risk by forming secondary tumors in other organs. More...

Detecting and analyzing these cells can play a crucial role in diagnosing and treating various cancers. However, the efficient capture of CTCs from blood has proven to be difficult, especially given the complexities and costs associated with incorporating antibodies into micro-sized devices. Although microfluidic systems using antibodies have shown promise, incorporating antibodies into specific regions of microscale devices involves complex chemical processes, ultimately raising production costs and hindering scalability. Now, scientists have developed a simple, cost-efficient microdevice that can detect cancer cells from blood with high sensitivity.

This novel microfluidic diagnostic device, developed by researchers at Chiba University (Chiba, Japan), incorporates microcone arrays to enhance the capture of cancer cells from blood. The team fabricated the device by imprinting polycarbonate (PC) sheets with microcone arrays using thermal nanoimprint lithography (T-NIL), a heat-based microfabrication technique. These microcones, approximately 30 micrometers in size, were arranged in a hexagonal pattern and featured nanometer-scale surface roughness that allowed for efficient binding of anti-human epithelial cell adhesion molecule antibodies. The antibody-coated PC sheets were sandwiched between a glass slide and a flat plate to form microchannels. The scientists tested various orientation angles of the microcone arrays within the microchannels to evaluate their influence on cancer cell capture behavior.

During experimental testing, the microfluidic device successfully captured human breast cancer (MCF-7) and human lung cancer (A549) cells from blood samples. The findings, published in Lab on a Chip, show that the device maintained a capture efficiency of over 90% for MCF-7 cells even at high flow rates, particularly when microcone orientation angles were set at 15° or 30°. To further demonstrate the system’s diagnostic capability, the researchers also performed immunostaining using fluorescent dyes to label and observe specific proteins in the captured cells. The labeled cancer cells remained trapped within the microchannels and could be easily distinguished from normal cells under fluorescence microscopy. This diagnostic device presents a highly sensitive and minimally invasive approach to cancer detection. It may also aid in monitoring treatment efficacy and identifying cancer recurrence through simple blood tests.

"We hope that through our new microfluidic system, even simple blood tests can be utilized to aid in the early diagnosis of cancer. It may also be useful for verifying the effectiveness of cancer treatment and monitoring recurrence after treatment," said Professor Masumi Yamada, lead developer of the device.

Related Links:
Chiba University


New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
Pipette
Accumax Smart Series
New
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new test is redefining access to early endometrial cancer detection (Photo courtesy of Shutterstock)

Non-Invasive Liquid-Based Cytology Test Enables Early Endometrial Cancer Detection

Endometrial cancer is the fourth most common cancer among women in the United States, with over 69,000 new cases expected in 2025. Yet many diagnoses occur late, particularly in women who face inconclusive... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.